Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Theravance Biopharma, Inc. Concurrent Ordinary Shares and Convertible Senior Notes Offerings
Davis Polk advised the joint book-running managers in connection with a $100.1 million SEC-registered offering of 3,850…
Davis Polk Advises Roche Holdings on Its $1.5 Billion Notes Offering
Davis Polk advised Roche Holdings, Inc. in connection with its Rule 144A/Regulation S offering of $650 million aggregate…
iRhythm Technologies, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the initial public…
Davis Polk Advises Advanced Accelerator Applications S.A. on Its Follow-On Offering
Davis Polk advised Advanced Accelerator Applications S.A. on its approximately $150 million SEC-registered follow-on…
Versartis Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $60 million follow-on offering of 4,898,000 shares…
Davis Polk Advises AC Immune SA on Its Initial Public Offering
Davis Polk advised AC Immune SA in connection with its $75.9 million U.S. initial public offering. AC Immune sold 6,900,000…
Davis Polk Advises Shire plc on Its $12.1 Billion Notes Offering
Davis Polk advised Shire plc on the $12.1 billion SEC-registered debt offering by its wholly owned subsidiary, Shire…
Evolent Health Secondary Offering
Davis Polk advised the representatives of the several underwriters, in connection with a secondary offering of 7,500,000…
OncoMed Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the sole book-running manager and representative of the several underwriters in connection with a $63.3…
Pfizer Acquires Medivation
Davis Polk is advising J.P. Morgan Securities as financial adviser to Medivation, Inc. in connection with its approximately …